Switzerland Tumor Ablation Market – Industry Trends and Forecast to 2030

Switzerland Tumor Ablation Market Analysis and Size

Increasing incidence of cancer diseases are the major factors that boosted the market demand in the forecast period. Presently, numerous research studies are taking place, which is anticipated to create a competitive advantage for different manufacturers to develop new, innovative, and advanced ablation drugs that are anticipated to provide other opportunities in the tumor ablation market. Major market players are considerably investing in R&D to launch minimally invasive and innovative tumor ablative solutions, boosting market growth.

Data Bridge Market Research analyses a growth rate in the tumor ablation market in the forecast period 2023-2030. The expected CAGR of tumor ablation market is tend to be around 13.70% in the mentioned forecast period. The market is valued at USD 96.65 million in 2022, and it would grow upto USD 269.95 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Switzerland Tumor Ablation Market Scope and Segmentation

Market Definition

Tumor ablation is the minimal invasive treatment that is used to completely destroy or inactive the cancer cells and tumors. Tumor ablation has several advantages as it makes the recovery easy and quick; and also it provides relief to patients who are hesitant to go for a surgery. It also ensures the accuracy in destruction of tumor cells without actually damaging the uninfected cells.

Switzerland Tumor Ablation Market Dynamics

Drivers

• Increasing Partnerships and Mergers

There are several market players that undergo several partnerships and agreements that are helping in boosting the growth of the market. The market players have adopted numerous strategic initiatives such as partnerships, mergers, product launches, and acquisitions to withstand their position in the market. For instance, Auris Health announced a partnership with Ethicon to develop robotically-assisted bronchoscopy tumor ablative systems in 2018. Furthermore, BD, the largest global medical technology company, announced that it had acquired Venclose in 2021. It is a medical technology company and its solutions for the treatment of chronic venous insufficiency (CVI), such as radio frequency (RF) ablation technology, with its catheters potentially decreasing post-operative pain. Thus, this factor boosts the market growth.

Opportunities

• Rising Regulatory Approvals from Organizations

Increasing regulatory approvals for technologically advanced ablation devices are boosting the market growth. For instance, Medtronic, a global leader in medical technology, announced that the DiamondTempTM Ablation (DTA) system treats patients suffering from recurrent, symptomatic paroxysmal atrial fibrillation (AF) who have been unresponsive to drug therapy, had received FDA approval in Europe in 2021. Thus, this factor boost the growth of the market.  

• Increasing Demand of Surgical Ablation

Increased incidence of liver and breast cancer and the wide unavailability of advanced tumor ablation techniques for these particular organs are the major factors expected to boost the market growth. These procedures provide minimal scarring, faster recovery, and increased safety. In addition to this, other factors such as patient comfort, quick surgery time, and cost-efficiency are expected to further increase the segment demand. Thus, this factor increases the growth of the market.  

Restraints/Challenges

• High Cost of Surgeries

The increasing cost of surgeries such as open surgery, laparoscopic and percutaneous lead to the hindrance in the market growth. Many developing countries cannot upgrade these surgeries into the hospitals as it is quite costly and the treatment process gets slower. Thus, this factor hinders the market growth.

This tumor ablation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tumor ablation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Switzerland Tumor Ablation Market Scope

The tumor ablation market is segmented on the basis of  type, types of treatment, technology, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Chemical Ablation
• Thermal Ablation
• Others

Technology

• Radiofrequency
• Microwave
• Cryoablation
• Irreversible Electroporation (IRE)
• High Intensity Focused Ultrasound (HIFU)
• Laser
• Fluoroscopy
• Ultrasound
• CT
• MRI Imaging
• Others

Types of Treatment

• Open Surgery
• Laparoscopic
• Percutaneous

Application

• Liver
• Kidney
• Bone
• Lung
• Uterine Fibroid
• Prostate
• Breast
• Others

End User

• Hospitals
• Oncology Center
• Others

Distribution Channel

• Direct Sales
• Third Party Distributors

Competitive Landscape and Switzerland Tumor Ablation Market Share Analysis

The tumor ablation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Switzerland presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tumor ablation market.

Key players operating in the tumor ablation market include:

• Medtronic (Ireland)
• AngioDynamics (U.S.)
• Boston Scientific Corporation (U.S.)
• BIOTRONIK SE & Co KG (Germany)
• EDAP TMS (France)
• HealthTronics, Inc. (U.S.)
• Misonix (U.S.)
• Medical Devices Business Services, Inc. (U.S.)
• Erbe Elektromedizin GmbH (Germany)
• MERMAID MEDICAL A/S (Denmark)
• BTG International Ltd (U.K.)
• BVM Medical Limited (U.K.)
• COMSOL INC. (Sweden)
• Cortex Technology (Denmark)
• CooperSurgical, Inc. (U.S.)
• AtriCure, Inc (U.S.)
• Abbott (U.S.)
• Integra LifeSciences (U.S.)
• Smith+Nephew (U.K.)
• CONMED Corporation (U.S.)

SKU-56428